Daniel Lyons, Ph.D., CFA
Daniel Lyons is a Portfolio Manager and Research Analyst on the Health Care and US Small/Mid-Cap Growth Teams at Janus Henderson Investors, a role he has held since 2018. Prior to this, he was a research analyst from 2000. He focuses on biotechnology and life science tools sectors for the Health Care Sector Research Team. Daniel started consulting for Janus in 1997 and joined the research team full time in 2000.
Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 23 years of financial industry experience.